Royal Bank of Canada’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.28M Buy
100,000
+19,900
+25% +$1.39M ﹤0.01% 2240
2025
Q4
$5.32M Buy
80,100
+10,700
+15% +$692K ﹤0.01% 2380
2025
Q3
$4.67M Buy
69,400
+19,300
+39% +$1.53M ﹤0.01% 2732
2025
Q2
$4.37M Buy
50,100
+50,000
+50,000% +$3.92M ﹤0.01% 2673
2025
Q1
$7K Hold
100
﹤0.01% 6253
2024
Q4
$8K Sell
100
-6,900
-99% -$511K ﹤0.01% 6402
2024
Q3
$469K Sell
7,000
-59,800
-90% -$4.91M ﹤0.01% 4148
2024
Q2
$7.57M Buy
66,800
+61,800
+1,236% +$7.81M ﹤0.01% 1863
2024
Q1
$694K Buy
+5,000
New +$628K ﹤0.01% 3745
2023
Q4
Sell
-57,100
Closed -$5.33M 7226
2023
Q3
$5.33M Buy
+57,100
New +$6.44M ﹤0.01% 2040
2022
Q1
Sell
-2,400
Closed -$322K 7797
2021
Q4
$322K Buy
+2,400
New +$345K ﹤0.01% 4865
2021
Q3
Sell
-4,800
Closed -$512K 7671
2021
Q2
$512K Hold
4,800
﹤0.01% 4250
2021
Q1
$431K Sell
4,800
-6,000
-56% -$563K ﹤0.01% 4316
2020
Q4
$998K Hold
10,800
﹤0.01% 3486
2020
Q3
$1.11M Hold
10,800
﹤0.01% 3181
2020
Q2
$1.09M Hold
10,800
﹤0.01% 3100
2020
Q1
$727K Buy
+10,800
New +$672K ﹤0.01% 3290

Other funds holding DXCM

Royal Bank of Canada's DXCM Position: Q1 2026 in Review

Royal Bank of Canada reduced its DexCom (DXCM) stake by 22% in Q1 2026, selling an estimated $39.4M and leaving 1,974,424 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #568.

Royal Bank of Canada first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $213M in Q3 2025. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Royal Bank of Canada held 1,974,424 shares of DexCom worth $124M as of Q1 2026.
  • Royal Bank of Canada sold 565,324 DexCom shares in Q1 2026, an estimated $39.4M.
  • DexCom made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #568 holding.
  • Royal Bank of Canada first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's DexCom position peaked at $213M in Q3 2025.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.